Revolution Medicines (RVMD)
Develops RAS(ON) therapeutics for KRAS-driven and broad RAS-driven solid tumors.
$193.05
After hours−0.02 (−0.01%)
At close$193.07(+0.16%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 43 days
EPS estimate
−$2.40
Revenue estimate
$22.6M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$1.12−$1.13−$1.31−$1.61−$1.86−$2.29−$3.06Pending
Estimate−$1.01−$1.12−$1.14−$1.42−$1.58−$1.84−$2.04−$2.40
Surprise−10.9%−0.9%−15.1%−13.4%−17.7%−24.5%−50.0%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$261.6M——————Pending
Estimate$375.0K$1.2M$27.5M$1.7M$3.7M$2.4M$1.8M$22.6M
Surprise+69,657.9%———————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.82 | — | — |
| Sep 2028 | −$1.23 | — | — |
| Jun 2028 | −$1.44 | — | — |
| Mar 2028 | −$1.25 | — | — |
| Dec 2027 | −$1.30 | — | — |
| Sep 2027 | −$1.54 | — | — |
| Jun 2027 | −$1.68 | — | — |
| Mar 2027 | −$1.78 | — | — |
| Dec 2026 | −$2.09 | — | — |
| Nov 2026 | −$2.40 | — | — |
| Aug 2026 | −$2.04 | −$3.06 | −50.0% |
| May 2026 | −$1.84 | −$2.29 | −24.5% |
| Feb 2026 | −$1.58 | −$1.86 | −17.7% |
| Nov 2025 | −$1.42 | −$1.61 | −13.4% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Feb 2020 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.82 | — | — | $652.4M | — | — | — |
| Sep 2028 | −$1.23 | — | — | $525.0M | — | — | — |
| Jun 2028 | −$1.44 | — | — | $450.0M | — | — | — |
| Mar 2028 | −$1.25 | — | — | $280.0M | — | — | — |
| Dec 2027 | −$1.30 | — | — | $405.1M | — | — | — |
| Sep 2027 | −$1.54 | — | — | $313.4M | — | — | — |
| Jun 2027 | −$1.68 | — | — | $258.1M | — | — | — |
| Mar 2027 | −$1.78 | — | — | $225.3M | — | — | — |
| Dec 2026 | −$2.09 | — | — | $160.7M | — | — | — |
| Nov 4, 2026 | −$2.40 | — | — | $22.6M | — | — | — |
| Aug 5, 2026 | −$2.04 | −$3.06 | −50.0% | $1.8M | — | — | +0.3% |
| May 6, 2026 | −$1.84 | −$2.29 | −24.5% | $2.4M | — | — | −5.7% |
| Feb 25, 2026 | −$1.58 | −$1.86 | −17.7% | $3.7M | — | — | −1.1% |
| Nov 5, 2025 | −$1.42 | −$1.61 | −13.4% | $1.7M | — | — | +3.4% |
| Aug 6, 2025 | |||||||
| May 7, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 26, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 8, 2023 | |||||||
| Feb 27, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 11, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 2, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 30, 2020 | |||||||
| Feb 13, 2020 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 |